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Abstract

International research suggests dysmenorrhea is a common problem among young adult
women, with a significant impact on their daily functioning. However, limited research has been
conducted on dysmenorrhea in young women in the U.S. The current study analyzed the
prevalence, impact, and treatment of dysmenorrhea among 976 young adult women living within
the U.S. Using a cross-sectional design, a questionnaire based on previous literature was created.
It was then distributed to women between the ages of 18-28 through university email and
participant initiated social media distribution. The mean age of participants was 22.27, 85%
endorsed dysmenorrhea. Seventy percent of women rated their average menstrual cramping as
moderate to severe on the Numeric Pain Rating Scale, and 70% endorsed experiencing at least
one incidence of severe pain within the last 6 months. Moderate positive correlations were found
between level of menstrual cramping and limitations in work around the home, physical activity,
and social leisure activity. Additionally, 32% endorsed a moderate to severe impact on school.
Despite high levels of pain, 49.4% of participants with dysmenorrhea had not discussed their
symptoms with a healthcare provider within the last year. Forty-six percent of participants
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indicated it was not at all helpful to speak to their healthcare provider about their menstrual
cramping. Participants endorsed using an average of 4.75 treatment strategies for their menstrual
cramping, a majority of which were home remedies. Greater pain was moderately correlated with
more treatment strategies used. This study suggests moderate to severe dysmenorrhea may be
highly prevalent in the United States amongst college educated young women. Moderate to
severe dysmenorrhea effects daily activities, and yet is not likely to be discussed at length with
healthcare providers.
Keywords: Dysmenorrhea, Menstruation, Menstrual Cramping, Women’s Health, Healthcare
communication
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Chapter 1
Introduction

Dysmenorrhea, otherwise known as painful cramping that occurs with menstruation, is
the most common form of pelvic pain experienced by all women (Lacovides, Avidon, & Baker,
2015; Osayande & Mehulic, 2014). It is estimated between 45-95% of women suffer from
dysmenorrhea (Proctor & Faruqhar, 2006). However, the prevalence rates of dysmenorrhea vary
significantly due to the vast range of definitions and are suspected to be underestimates due to
lack of documentation of the condition (Grandi et al., 2012; Ju, Jones & Mishra, 2013; Lacovides
et al., 2015; Proctor & Faruqhar, 2006). There are two types of dysmenorrhea: primary
dysmenorrhea (PD), where there is no known etiology for the pain, other than the production of
uterine prostaglandins, and secondary dysmenorrhea (SD), where an underlying cause is present,
most often endometriosis (Proctor & Faruqhar, 2006). However, the cause of pelvic pain is not
what impacts the quality of life, rather it is the pain itself (Souza et al., 2011).
The onset of dysmenorrhea is typically one year after menarche, and peak prevalence
occurs in the late teens and early twenties (Osayande & Mehulic, 2014). Several studies have
found a positive correlation between dysmenorrhea and earlier menarche (Chia et al., 2013;
Grandi et al., 2012; Ju et al., 2013). Additionally, young women who have not yet experienced
live births tend to experience the most debilitating dysmenorrhea pain (Ju et al., 2013). In a
review of the current literature, young women were found to have the highest prevalence of
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dysmenorrhea, with an estimated range of 67 - 90% in ages 17-24 (Ju et al., 2013). However,
most studies examining rates of dysmenorrhea have been conducted internationally.
The most recent studies conducted in the U.S. regarding the prevalence of dysmenorrhea
in young women and how they managed their symptoms are longitudinal studies with data
collection dating back to the 1980s (Harlow & Park, 1996; Weissman, Hartz, Hansen, &
Johnson, 2004). The current statistics on dysmenorrhea for young women within the U.S. are
limited, and as a whole, recent data on the prevalence of dysmenorrhea in women of
reproductive age is sparse (Ju et al., 2013). However, international studies on university students
suggest high prevalence. (Aktaş, 2015; Chia et al., 2013; Ju et al. 2013; Habibi, Soo Lee Huang,
Ying Gan, Zulida, & Morteza Safavi, 2015; Lam & Charm, 2015; Ortiz, 2010; Unsal, Ayranci,
Tozun, Arslan & Calik, 2010). Internationally, college aged women experience higher rates of
dysmenorrhea and the most extreme and incapacitating cases of dysmenorrhea (Ortiz, 2010;
Polat et al., 2009; Unsal et al., 2010). When looking at women 26 and younger, the estimates of
debilitation increase to 41% (Ju et al., 2013). Within the university population in Italy 84% of
participants reported menstrual pain, 55% reported menstrual pain and the need for medication,
31% reported menstrual pain and absenteeism, and 25% reported need for medication and
absenteeism (Grandi et al., 2012). Within Turkey, 72.7% of students reported dysmenorrhea, and
66.2% described their pain as moderate to severe (Unsal et al., 2010).
Disease Burden
Not only do many women experience the pain of dysmenorrhea, but they also experience
the burden of disruption it has in their lives (Chia et al, 2013). When examining valid studies
conducted on pelvic pain, dysmenorrhea caused a high disease burden (Latthe, Latthe, Say,
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Gulmezoglu, & Khan, 2006). It is estimated one third of women accrue absences from work and
school due to their debilitating dysmenorrheic pain (Grandi et al., 2012). The International
Association for the Study of Pain (IASP) estimated 10-15% of women miss 1-3 days of work
each menstrual period due to dysmenorrhea (IASP, 2007). Additional estimates range from 140
million to 600 million missed work hours per year due to dysmenorrhea within the US, and the
estimated economic consequences at $2 billion per year (El-Minawi & Howard, 2000;
Ostrzenski, 2002). While examining dysmenorrhea within the US adolescent population,
O’Connell, Davis, & Westhoff (2006) estimated at least 2 million teenage girls suffer from
severe and debilitating dysmenorrhea. In Hong Kong one third of adolescent female participants
reported experiences of debilitating dysmenorrhea (Chan, Yiu, Yuen, Sahota, & Chung, 2009).
Outdated research suggests dysmenorrhea to be the leading cause for school and work absences
for adolescent females (Ylikorkala & Dawood, 1978).
Internationally, women often experience negative impacts in their ability to concentrate,
conducting their studies, physical activity, psychosocial well-being, sleep, daily chores, ability to
leave the home, participation in sports and social events, and attending school or work (Chan et
al., 2009; Chia et al., 2013; Grandi et al., 2012; Ortiz, 2010; Wong, 2011). When monitoring
women with a history of dysmenorrhea using activity data loggers worn on the body, researchers
found a 40% decrease in activity when participants were experiencing moderate to severe
dysmenorrhea (Chantler, Mitchell, & Fuller, 2009). Additionally, there is a decrease in healthrelated quality of life amongst women suffering from dysmenorrhea (Lacovides et al., 2013;
Unsal et al., 2010). Specifically, within western Turkey, dysmenorrhea had a 72.7% prevalence
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rate amongst university females and it was found to have significant negative effects on the
quality of life of the students (Unsal et al., 2010).
Involvement of Professional Healthcare
Even though women face the burden of dysmenorrhea, they typically avoid medical
involvement and do not discuss their symptoms with health care providers, even in severe cases
(Aktaş, 2015; Berkley & McAllister, 2011; Chia et al., 2013; Lam & Charm, 2015; O’Connell et
al., 2006; Ortiz, 2010; Proctor & Faruqhar, 2006). Many women consider menstrual pain to be
normal, leading them to disregard their dysmenorrhea symptoms, and feeling as though it is
“unworthy” of reporting to others (Berkley & McAllister, 2011; Ortiz, 2010). Additionally, many
women overlooked the impact dysmenorrhea had on their lives (Chia et al., 2013). Another
barrier in communicating with healthcare providers is women feeling like menstruation is too
“embarrassing” to talk about (Chan et al., 2009). Recently, in Hong Kong, young adult women
reported they were more likely to use the internet to find treatment for their dysmenorrhea than
they were to discuss it with healthcare providers (Lam & Charm, 2015). These women preferred
self-care strategies and turning towards the internet because it prevented them from having to
engage in “embarrassing” conversations.
Women believing pain with menstruation is either normal or too “embarrassing” to
discuss may lead to harmful neglecting of chronic health diseases, and many of these chronic
health diseases may lead to problems with fertility (Osayande & Mehulic, 2014). Additionally,
dysmenorrhea is often present in women who suffer from other pain conditions such as Irritable
Bowel Syndrome, and Urinary Calculosis (Berkley & McAllister, 2011). Berkley and McAllistor
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(2011) suggest treating dysmenorrhea may also assist in relief from these other co-morbid
conditions.
Treatment
Despite the high prevalence of dysmenorrhea, effective treatment methods remain underresearched (Ortiz, 2010). The first line of treatment for dysmenorrhea is nonsteroidal antiinflammatory drugs (NSAID) to treat the pain (Daniels, Robbins, West, & Nemeth, 2009;
Osayande & Mehulic, 2014; Proctor & Faruqhar, 2006). Research on adolescents within the US
found nearly all the participants used prescription and over-the-counter (OTC) medications to
treat their symptoms (O’Connell et al., 2006). Some used medications demonstrated as effective
in dysmenorrhea such as NSAIDs, and some used medications with no proven benefit, such as
acetaminophen, pamabrom, and narcotics. When used therapeutically, “Medications should be
taken one to two days before the anticipated onset of menses and continued on a fixed schedule
for two to three days.” (Osayande & Mehulic, 2014, pp.344). The research findings are mixed
regarding which NSAIDs are more effective in treating symptoms. Literature reviews have
suggested OTC Naproxen may be most effective (Milsom et al., 2002).
Additionally, oral contraceptives may be used for preventing ovulation from occurring,
however, the use of oral contraceptives in PD suggests limited evidence as to the effectiveness
(Osayande & Mehulic, 2014; Ou., Hsu, Lai, Lin, & Lin, 2012; Proctor & Faruqhar, 2006).
Recent studies have been conducted on the effectiveness of new treatments such as acupuncture,
vibrating tampons, Vitamin K injections, essential oil massage, and therapeutic doses of vitamins
and supplements such as Fennel, however, the evidence is limited to small random clinical trials
(Chao, Callens, Wade, Abercrombie, & Gomolak, 2014; Witt, Strickland, Cheng, Curtis, &
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Calkins, 2013). Additionally, exercise has often been thought to be beneficial in treating PD,
however this research typically involves small sample sizes and questionable methodology,
suggesting further research needs to be conducted on the effectiveness of exercise on PD
symptoms (Daley, 2008).
Often, women prefer to self-manage dysmenorrhea, and notably, those who self-managed
were more likely to experience inability to function in their daily activity (Ortiz, 2010). Selftreatment often involves using heat, hot beverages, and rest to treat their symptoms (Chia et al.,
2013). For the women in Hong Kong turning to the internet for self-treatment strategies, they
preferred more narrative sites such as blogs and forums, than medical oriented websites. The
authors found this concerning due to the lack of peer review on sites such as these, which they
state may lead to more problems than solutions (Lam & Charm, 2015).
Social Influence
Chris Bobel, author of the book, New Blood: Third-wave Feminism and the Politics of
Menstruation, explains how the women’s health movement grew during the 1970s and 80s
(Bobel, 2010). She describes how the medical system, which was both designed and run mostly
by men, ignored and overlooked the bodily experiences unique to women, leading to failure to
provide adequate women’s health care. In regard to menstruation within Western societies
women are instructed to keep their new status of “womanhood” a secret (Marván, Luisa,
Morales, & Cortés-Iniestra, 2006). Bobel illuminates the powerful message distributed to young
women regarding their bodies and their place in society, “It will do things that we need not speak
of. You will relate to it primarily as a consumer.” (2010, p. 27).

DYSMENORRHEA

7

As Lorber states in the foreword of Bobel’s book, “Menstruation was something to
minimized, managed, and made invisible” (2010, p. xi). Another trend in the history of women’s
health is to trivialize their menstrual pain as “Just in their head” perpetuating the notion of
instability in women (Bobel, 2010). In fact, up until the 21st century, the medical literature often
ascribed pain during menstruation to emotional and psychological problems (Proctor & Faruqhar,
2006). Therefore, “women believed it may be unwise to focus on experiences that makes them
different than men for fear they may be used against them” (Bobel, 2010, p. 29; Delaney, Lupton,
& Toth, 1988). This view of women’s menstrual pain may be a reason why dysmenorrhea has not
been a focus in medicine.
Research Limitations
Although it is known that dysmenorrhea has a high prevalence rate and a significant
impact, it has remained largely ignored by those in the pain community (Berkley & McAllister,
2011). In Pubmed and Sciencedirect searches conducted in 2011 by Berkley and McAllister, they
found 0.1% of “pain” papers acknowledged dysmenorrhea. Additionally, they note, “While 2988
grants in the USA received funds for “pain” research, only 15 have been funded for research that
includes dysmenorrhea: 0.5% of pain research.” (Berkley & McAllister, 2011, p. 1940).
Furthermore, only limited information on dysmenorrhea was collected, excluding both severity
and duration, and they stated, “The dysmenorrhea information has not been analyzed or
reported.” (Berkley & McAllister, 2011, p. 1940). As Laura Fingerson writes in Girls in Power:
Gender, body, and Menstruation in Adolescence,
It is odd that such an integral and routine event in women’s lives, which has
significant implications for women’s health and well-being over the life course,

DYSMENORRHEA

8

not to mention the salience it holds in adolescence, has generally been ignored in
social research (2006, p. 4).
Additionally, appropriate patient-reported outcome measures of dysmenorrhea symptoms
and functional impact are currently lacking ( Nguyen et al., 2017). Nguyen et al., found the
Menstrual Symptom Questionnaire (MSQ; Chesney & Tasto, 1975), Moos Menstrual Distress
Questionnaire (MDQ; Moos, 1968), Verbal Multidimensional Scoring Assessment for
Dysmenorrhea (VMSAD; Andersch & Milsom, 1982), McGill Pain Questionnaire (MPQ;
Melzack, 1975 & 1987) and Symptom Severity Scale (SSS; Biberoglu & Behrman, 1981) all to
be lacking in sufficient evidence for content validity, citing reasons such as, “minimal concept
coverage (SSS, MPQ), insufficient input from patients (VMSAD, MDQ), and items assessing
multiple concepts (MSQ)” (Nguyen et al., 2017, p. 2041-2042).
Purpose of this Study
This study surveyed young women living in the USA regarding their current symptoms
of dysmenorrhea and the impact it has on their ability to function. It assessed the symptoms they
experience during menstruation and the severity of their menstrual cramping and how it impacts
their daily living. Additionally, information was gathered regarding the level of communication
they have had with their healthcare providers and how they treat their dysmenorrhea symptoms.
Due to the measurement limitations mentioned above, this study broadly surveyed women’s
experiences using questions developed by the researcher based on the previous literature (Aktaş,
2015; Chan et al, 2009; Chia et al, 2013; Grandi et al, 2012; Habibi et al., 2015; Ortiz, 2010;
Unsal et al, 2010; Wong, 2011).
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Hypotheses
The primary contribution of this study is to describe young women’s experience of
dysmenorrhea in the United States.
Hypothesis 1: The majority of women in this study will experience moderate to severe
dysmenorrhea measured by the Numeric Pain Rating Scale (NPRS; McCaffery & Beebe, 1993).
Hypothesis 2: There will be a positive correlation between average menstrual cramping
as measured by the NPRS and levels of impaired daily functioning as measured by the 8 function
items on the modified Dysmenorrhea Daily Diary (DysDD; Nguyen et al., 2017).
Hypothesis 3: The majority of women will not have talked to their providers at length
regarding their menstrual pain as measured by the item regarding discussing menstrual pain with
the healthcare provider.
Hypothesis 4: Pain severity will be positively correlated with the total number of
treatment methods used.
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Chapter 2
Methods
Participants
Upon distribution, 1,067 participants started the survey. One hundred forty-four
participants did not endorse pelvic pain or cramping with menstruation and were discontinued
from the remainder of the survey. Eight hundred seventeen participants endorsed pelvic pain and
cramping with menstruation and continued the survey. For questions towards the end of the
survey fewer participant answers were recorded, such as questions on communication with
providers. The sample size for each item will be listed for each descriptive statistic in the tables
below. All participants identified as female, were between the ages of 18-28, and were living in
the United States. The average age of participants was 22.27 (SD = 3.2). The average completed
grade level was 15.78 (SD = 2.4). Of the participants, 75.4% identified as Non-Hispanic white,
8.5% as bi-racial, 6.2% as Latina/Hispanic American, 3.2% East Asian, 1.4% black, AfroCaribbean, or African American, 1.1% Middle Eastern, 0.7% Native American, 0.5% South
Asian, and 1.8% as “Other” (see Table 1) .
Procedure
Following IRB approval from George Fox University, the opportunity to participate in
the current cross-sectional analytical survey was distributed to all undergraduate and graduate
students at George Fox University via university email. Participants completed informed
consent, responded to demographic items, provided general menstruation information, and
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Table 1
Demographics
Variable
Age

n

Percentage

965

M (SD)
22.27 (3.18)

Ethnicity
Non-Hispanic White
Latina/Hispanic
American
East Asian
Black, Afro-Caribbean
or African American
Middle Eastern

735

75.4

60

6.2

31

3.2

14

1.4

11

1.1

Native American

7

.7

South Asian

5

.5

Bi-racial

83

8.5

“Other”

18

1.8

Grade Level

962

15.78 (2.37)

disclosed whether or not they had experienced symptoms of dysmenorrhea in the last six months
(see Appendix A for informed consent). Those who did not endorse dysmenorrhea symptoms
were discontinued from the remainder of the survey. Those who did endorse dysmenorrhea
symptoms then completed the remainder of the survey regarding impact on functioning,
treatment strategies, and communication with healthcare providers. Upon completion of the
survey all participants were given the opportunity to be placed into a drawing for 20 ten-dollar
gift certificates to Amazon. Students who received the survey via university e-mail shared the
link on social media. Although the original intention was to gather an accurate response rate,
once the survey link was widely shared by students, the investigator decided to invite
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participation through the Society for Menstrual Cycle Research listserv. Diva Cup International
contacted the researcher and requested to further distribute the survey link via their social media
platform. A majority of participants, 68.6%, endorsed hearing of the survey through the
university setting and email, and 30.8% through social media or a friend.
Measures
Participants responded to survey questions regarding demographic characteristics,
menstrual and dysmenorrhea symptoms, ability to function during dysmenorrhea, methods of
treatment for dysmenorrhea, communication with healthcare providers regarding dysmenorrhea,
and previous reproductive diagnoses (see appendix B for survey). Given the difficulties with
finding validated and reliable measures for this population, the primary questionnaire used in this
study was created based on previous studies in the literature (Aktaş, 2015; Chan et al, 2009; Chia
et al, 2013; Grandi et al, 2012; Habibi et al., 2015; Ortiz, 2010; Unsal et al, 2010; Wong, 2011).
The survey, which consisted of 34 questions, was piloted on a group of university women.
Additionally, public health personnel were consulted regarding survey content and layout.
Menstrual Pain Measure. The definition of dysmenorrhea used in this study was
consistent with the current literature, including pain in the lower abdomen, back, and/or thighs
associated with menstruation and may be accompanied by nausea, vomiting, diarrhea, and
fatigue (Lacovides et al., 2015; Osayande & Mehulic, 2014; Proctor & Faruqhar, 2006). The
intensity of menstrual pain and cramping was assessed according to the Numeric Pain Rating
Scale (NPRS), a numeric VAS (Visual Analogue Scale) with integers 0-10. Zero was considered
no pain, 1-3 considered mild, 4-6 moderate, and 7-10 severe (McCaffery & Beebe, 1993). In
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other pain populations, the NPRS has a test retest reliability of .96 and .95 respectfully (Ferraz et
al., 1990).
Measure of Impact on Functioning. Modified items from the DysDD were used to
assess the impact of menstrual cramps on functioning in participants who had experienced
dysmenorrhea within the past six months (Nguyen et al., 2017). The reliability of the original full
DysDD within one menstrual cycle was adequate (weighted kappa: 0.5-0.7). The measure
showed concurrent validity, however, reliability between cycles varied (Nguyen et al., 2017). In
this study, select items on functioning were utilized such as, “In the past 6 months, how much
did pelvic pain or cramping during menstruation limit you in your physical activity?”
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Chapter 3
Results
Menstruation
This study was conducted with 976 female participants. The number of missing values
ranged from 0-11 and the mean was 2.17 (SD = 4.27). A correlation was conducted between
average menstrual cramping and total number of missing values. The correlation was not
significant, r = .03, p = .45. Therefore, there was no pattern to the missing values related to their
menstrual cramping pain. Because the sample size was sufficiently large, missing values were
not replaced. Additionally, the survey consisted of single item questions and no totals or
averages of any validated measures were computed further supporting the decision not to replace
missing values in a iterative linear interpolation.
Characteristics of the participants’ menstrual cycles are displayed in Table 2. The mean
age of menarche was 12.34 (SD = 1.64). Age of menarche had a significant inverse correlation
with menstrual cramping. The correlation relationship was strong indicating earlier menarche
onset was related to higher menstrual cramping, r = -0.87, p = .015. The average period length
for participants was 5.29 days (SD = 1.64). Of the participants, 81% reported moderate to heavy
bleeding during menstruation. Only 7.1% of participants endorsed a history of childbirth.
When thinking back on the last six months, abdominal cramping was the most frequently
endorsed symptom during menstruation, with a prevalence of 91.9% (n = 968), participants
categorized their level of cramping 24.6% mild, 41.3% moderate, and 26% as severe when using
terminology. Other common co-occurring symptoms were bloating, tension/irritability/mood
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swings/crying spells, backache, swollen or tender breasts, appetite changes, and other various
symptoms presented in Table 3. Using a 0-10 rating scale, 71% of participants rated their overall
menstrual discomfort, including all symptoms, a 5 or higher (Item 12).

Table 2
General Menstruation Information
Item
Age of Menarche

N
962

M (SD)
12.34 (1.64)

Number of Periods in the last 6 months

963

5.39 (1.43)

Average duration of menstruation (days) 967

5.29 (1.64)

Dysmenorrhea
Eighty-five percent endorsed any degree of cramping or pain in the pelvic area along with
menstruation (Item 13). Those who did not endorse pelvic pain or cramping were discontinued
from the survey. Using the Numeric Pain Rating Scale of 0-10, 70.1% of participants rated their
average menstrual cramping as a 5 or higher, with an average of 5.39 (SD = 2.05) (Item 14).
Therefore, Hypothesis 1 was verified with a majority of women endorsing moderate to severe
dysmenorrhea. When rating their worst menstrual cramps in the last six months on the same
scale, 69.7% rated their worst pain as a 7 or higher, with an average of 7.38 (SD = 2.13) (Item
15). On average, participants reported 2.15 days (SD = .85) of cramping during each period over
the last 6 months. Demographic variables were considered to assess differences in menstrual
cramping. Because the majority of the sample received the survey through university e-mail, and
were college educated and living in the Pacific Northwest the only demographic variable
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Table 3
Symptoms with Menstruation
Symptom
Feeling Tired

n
965

% None
8.6

% Mild
25.4

% Moderate % Severe
44.2
21.8

Trouble Sleeping

958

44.6

26.9

18.6

9.9

Trouble with Concentration and Memory

960

54.2

27.4

14.3

4.2

Tension, Irritability, Mood
Swings, Crying
Spells

965

15

31.6

35.4

17.9

Anxiety

962

31.1

29.6

26.5

12.8

Depression

961

42.4

28.2

21.2

8.2

Abdominal Cramping

968

8.1

24.6

41.3

26

Joint/Muscle Pain

960

36.1

31.5

27.9

4.5

Leg Aches

958

58.2

22.4

15.8

3.5

Backache

963

24.5

28.8

33.1

13.6

Swollen or Tender Breasts

962

24.3

37.1

29.6

8.9

Upset Stomach/Nausea

960

37.4

30.8

23.0

8.8

Bloating

966

13.1

34.7

38.5

13.7

Constipation/Diarrhea

963

32.7

31

27.4

8.8

Headache/Migraine

959

37.6

29.1

23

10.2

Appetite Changes

960

25.6

32.8

31.6

10

analyzed was ethnicity. The sample was divided into white and non-white groups and the
ANOVA was not significant F (1, 719) = .67, p = .41.
Impact on Functioning
The impact of dysmenorrhea on functioning is displayed in Table 4. Means and standard
deviations were based on a 5-point scale, ranging from 0 (Not at all) - 4 (Extremely). The area of
functioning most impacted was physical activity with 52.9% of participants endorsing a
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moderate to extreme impact. Work around the home was also impacted with 50.5% of
participants endorsing moderate to extreme effects. Given the age range of the population
surveyed, most of which were enrolled in university, 42.8% of participants endorsed a moderate
to extreme impact on concentration, and 32.3% endorsed a moderate to extreme impact on
school. Correlation coefficients were computed among pain and the 8 scales of function. Using a
Bonferroni to control for type 1 error across the 8 correlations, a p value of less than .006 (.05 / 8
= .006) was required for significance. The results of the correlational analyses presented in Table
5 show that all 8 were statistically significant and were greater than or equal to .38, supporting
hypothesis 2. Specifically, the relationship between the pain and its impact on work around the
home, physical activity, and social leisure activity were all strong and greater than .52.

Table 4
Impact on Functioning
Item
n

Mean (SD)

%Not
at all

%
Slightly

Paid Work

793

.75 (.98)

53.6

School Work

796

1.07 (1.09)

Work around the
Home

793

Physical Activities

% Quite
a bit

% Extremely

26

%
Moderately
13.2

5.7

1.5

39.6

28.1

20

9.9

2.4

1.65 (1.17)

17.8

31.8

24.7

18.7

7.1

783

1.67 (1.07)

13.7

33.5

29.6

18.4

4.9

Social and Leisure
Activities

783

1.41 (1.08)

22.2

35

24.4

15.7

2.7

Relationships
with Other

782

.94 (1.01)

42.3

30.7

18.7

6.6

1.7

Ability to
Concentrate

783

1.38 (1.09)

23.1

36.7

23.4

12.9

4.0

Ability to Sleep

783

1.20 (1.11)

32.4

32.7

21.1

10.3

3.4
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Table 5
Correlation of Dysmenorrhea Pain and Functioning
Variable

Average pelvic pain or
cramps
Physical activities
Social or Leisure Activities
Relationships with others
Ability to concentrate
Ability to sleep
Paid work
School work
Work around the home

Average
pelvic pain
or cramps
1
n = 795
.53**
n = 776
.56**
n = 776
.39**
n = 775
.49**
n = 776
.49**
n = 776
.38**
n = 792
.41**
n = 795
.54**
n = 792

Physical
activities

1
n = 783
.72**
n = 783
.51**
n = 782
.56**
n = 783
.50**
n = 783
.46**
n = 774
.47**
n = 777
.62**
n = 774

Social or
Leisure
Activities

Relationshi
ps with
others

1
n =783
.63**
n = 782
.60**
n = 783
.52**
n = 783
.49**
n = 774
.56**
n = 777
.61**
n = 774

1
n = 782
.54**
n = 782
.44**
n = 782
.49**
n = 773
.40**
n = 776
.47**
n = 773

Note. *Correlation is significant at the 0.01 level (2-tailed).

Ability to
concentrate

Ability to
sleep

1
n = 783
.58**
n = 782
.40**
n = 774
.53**
n = 777
.55**
n = 774

1
n = 783
.39**
n = 774
.41**
n = 777
.46**
n = 774

Paid work

1
n = 793
.46**
n = 793
.47**
n = 791

School
work

1
n = 796
.52**
n = 793

Work
around the
home

1
n = 793
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Communication with Health Care Providers
Amongst the participants who endorsed dysmenorrhea, 49.4% of participants reported
they have not discussed their menstrual cramps with their provider at all within the last year,
with the average length of discussion a 2.97 (SD = 3.46) on a 0 (not at all) - 5 (briefly) - 10 (at
length) scale (Table 6). Hypothesis 3 was supported with 79.6% of participants endorsing their
level of conversation with their healthcare provider as Briefly discussed or less. Of the
participants, 7.8% had sought emergency care due to menstrual cramping. When rating their
comfort discussing menstrual pain with their provider, 44.2% rated their comfort as moderate or
below. On a 0 - 10 scale, 0 (not at all helpful), 5 (neutral), and 10 (very helpful), measuring how
helpful it was to speak to their health care provider regarding their menstrual cramping 75.1% of
women rated it a 5 or below, with 46.3% reporting it was not helpful at all to speak to their
healthcare provider. Relevant diagnoses amongst the participants are displayed in Table 7.

Table 6
Communication with Healthcare Provider
Item
N
Amount of Discussion with Healthcare Provider
773
within the Last Year 0 (Not at all) - 10 (Discussed
at Length)

Mean (SD)
2.98 (3.47)

Comfort Level Discussing Cramping with
Healthcare Provider 0 (Not at all) - 10 (Very
Comfortable)

771

6.5 (3.16)

Level of Help Discussing Cramping with
Healthcare Provider Was 0 (Not at all) - 10 (Very
Helpful)

774

3.32 (3.60)
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Table 7
Relevant Diagnoses
Diagnosis (n= 976)
Endometriosis

%
1.5

Uterine Fibroids

.6

Polycystic Ovary Syndrome

4.7

Infection in the last 6 months

1.7

None

77.9

Treatment Strategies
Treatment strategies endorsed by participants are presented in Tables 8-10. Showers and
baths, NSAIDS, sleep, heat, and warm beverages were the most common treatment strategies
used amongst participants. However, only 52% of women reported the use of NSAIDS to control
pain. On average participants used 4.75 (SD = 3.54) treatment strategies, and of those strategies
2.85 (SD = 2.25) were home remedies. A correlation coefficient was computed between
menstrual cramping and the total number of treatment methods used including home, alternative,
and medical. Participants with higher pain endorsed using more treatment strategies, with a
significant moderate sized correlation r = .31, p = .00. Therefore, hypothesis 4 was supported.
Additional Analyses
The sample was divided into 4 quartiles based on average menstrual pain. The 1st and 4th
quartile were compared to see if there were any differences between those with the lowest pain
and those with the highest pain on the impact of pain on function (work, school work, physical
activity etc.) and communication with healthcare provider. Independent samples t tests were
conducted and were significant except for comfort level discussing menstrual pain with
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Table 8
Medical Treatment Strategies
Treatment Method (n= 976)
Tylenol

%
33.9

Pamprin/Midol

18

NSAIDS

52

Narcotics

1.1

Contraception

20.3

Table 9
Home Treatment Strategies
Treatment Method (n = 976)
Warm Beverage

%
38.4

Sleep

50.6

Heat

48.1

Shower/bath

53.1

Exercise

30.5

TV/Distraction

36.7

Food or Drink

17.8

Alcohol

5.5

Marijuana

4.6
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Table 10
Alternative Treatment Strategies
Treatment Method (n = 976)
Acupuncture

%
.8

Massage

14.7

Yoga

13.6

Postural Adjustment

20.4

Dietary/Nutritional Supplement

5.6

Herbal

8.7

healthcare provider (see Table 11). Effect sizes for the differences between these means were
calculated. Effect sizes for all areas of function were very large, especially for social and leisure
activities. There was a moderate difference between those with lowest pain and those with
highest pain on discussing with health care provider (d’ = .71) and a small difference in
helpfulness (d’ = .27). However, there are no differences between the groups on comfort level
discussing cramping with their provider. Both groups scored in the “Moderate” range regarding
comfort.
The effect size was calculated of the mean average menstrual cramping in the present
study compared to the mean in each international study (see Table 12). The Cohen’s d ranged
from .0 to .17 indicating there was no meaningful difference between the present study and
international studies on reported average menstrual cramping. The effect size was calculated of
the worst cramping experienced by young adult participants in the current study compared to
adolescents in the US (see Table 13). The Cohen’s d was in the moderate range (d’ = .71).
Additionally, the effect size was calculated of the mean age of menarche in the present study
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Table 11
Differences Between Low and High Dysmenorrhea Pain Groups
Item
n Low LPG
n High HPG Mean
t
Pain
Mean
Pain
(SD)
Group (SD)
Group
(LPG)
(HPG)
Paid Work
232
.34 (.62) 131
1.35 (1.26)
-10.21

df

p

Cohen’s
d’

361

.00

1.02

School Work

233

.53 (.74)

132

1.71 (1.29)

-11.10

363

.00

1.12

Work Around
the Home

232

.91 (.89)

131

2.56 (1.14)

-15.38

361

.00

1.61

Physical
Activities

229

1.02 (.89) 130

2.44 (1.0)

-13.93

357

.00

1.50

Social and
Leisure
Activities

229

.74 (.78)

2.32 (1.01)

-16.52

357

.00

Relationships
with Others

229

.55 (.76)

130

1.64 (1.08)

-11.14

357

.00

1.17

Ability to
Concentrate

229

.81 (.82)

130

2.20 (1.18)

-13.10

357

.00

1.37

Ability to
Sleep

229

.58 (.76)

130

1.94 (1.25)

-12.83

357

.00

1.31

Discussed
Cramping
with the
Healthcare
Provider

228

2.16
(3.19)

126

4.66 (3.80)

-6.58

352

.00

.71

Comfort
Level
Discussing
Healthcare
Provider

226

6.84
(3.06)

127

6.36 (3.44)

1.34

351

.18

.15

Helpfulness
of Discussing
Cramping
with Provider

228

2.95
(3.67)

127

3.94 (3.62)

-2.47

353

.01

.27

130

1.75
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compared to the mean in each international study (see Table 14). The Cohen’s d was in the
moderate range for differences between this study sample and the Turkish sample, meaning that
women in Turkey had a significantly older age of menarche than women in the study. There
were no meaningful differences between the present study and the studies conducted in China,
Italy, and Mexico on mean age of Menarche.

Table 12
Average Level of Dysmenorrhea Pain in the Literature
Study
N
Mean (SD) Numerical df
Scale
Used
Present Study,
795
5.4 (2.05)
0-10
Johnson 2018

t

p

Cohen’s
d

Aktas, 2015

168

5.78 (2.45)

0-10

794

-5.27

.000

.17

Chia et al., 2013

191

5.0 (1.7)

0-10

794

5.44

.000

.17

Grandi et al, 2012

408

50.2 (22.4)

0-100mm

794

5.16

.000

.10

Ortiz, 2009

961

54.1(23.4)

0-100mm

794

-.19

.850

0

Note. *Comparison between study sample mean and international sample means.

Table 13
Menstrual Cramping at its Worst in the US
Study
N
Mean (SD) Numerical
Scale
Used
Present Study,
796
7.38 (2.13) 0-10
Johnson Campbell,
2018

df

t

P

O’Connell et al.,
76
8.6 (1.2)
0-10
795
-16.08
.000
2006
Note. *Comparison between study sample mean and US adolescent sample mean.

Cohen’s
d

.71**
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Table 14
Average age of Menarche in the literature and Comparison between study sample mean and
international sample means
Study
N
Mean (SD)
Df
t
p
Cohen’s d
Present study,
962
12.34 (1.64)
Johnson Campbell,
2018
Aktas, 2015

200

13.24 (1.36)

961

-17.11

.000

.60

Chia et al., 2013

240

12.5 (1.2)

961

-3.08

.002

.11

Grandi et al., 2012
Ortiz, 2009

408
1539

12.56 (1.32)
12.3 (1.5)

961
961

-4.21
.72

.000
.473

.15
.03
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Chapter 4
Discussion
Implications of the Results
This study surveyed 976 participants, ages 18-28, living in the United States regarding
symptoms of dysmenorrhea. The age range was selected due to peak prevalence of dysmenorrhea
occurring during late teens and early 20s (Osayande & Mehulic, 2014). Previous international
studies of its kind have ranged from 200 – 1,539 participants. To the researcher’s knowledge this
is the largest current sample surveyed in the United States, providing helpful data on the
prevalence of dysmenorrhea within this population. It is not considered representative because a
majority of participants in this study identified as white, were college educated, and lived in the
Pacific Northwest, differing from the greater US female population (Health Resources and
Services Administration- Office of Women’s Health, 2013). However, this is typical of studies in
other countries, whose samples were composed mainly of students from a single university.
Age of menarche was comparable to studies of this type conducted in China, Italy, and
Mexico, and differed from one study conducted in Turkey whose mean age was significantly
older (Aktas, 2015, Chia et al., 2013; Grandi et al., 2012; Ortiz, 2009). A minimal inverse
correlation was found between earlier menarche and dysmenorrhea, consistent with previous
literature which suggested younger menarche may lead to more symptoms of dysmenorrhea
(Chia et al., 2013; Grandi et al., 2012; Ju et al., 2013). Previous research has also found history
of childbirth reduces instances of dysmenorrhea, however, within this sample very few
participants endorsed a history of childbirth (Ju et al., 2013). Considering the high prevalence of
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dysmenorrhea amongst this sample it is possible the lack of history of childbirth may contribute
to this finding.
Of the various menstruation symptoms reported in the literature, as predicted, pelvic pain
and cramping was endorsed by a majority of the sample, prevalent amongst 85% of participants.
Women affected may be more likely to endorse severe pain numerically than when asked to
describe their pain with vocabulary. Only 26% of participants used the terminology “severe” to
describe their pain, yet slightly larger percentage of participants rated their average continuous
cramping within the severe range on a numerical scale. Furthermore, roughly 70% of women
reported experiencing at least one incidence of numerically rated “severe” pain within the last six
months. This finding provides reason to believe women may be minimizing the severity of the
cramping they experience when they discuss it and a numerical pain rating may be a more
helpful representation of their experienced level of pain.
The mean rating of menstrual cramping on average given by participants in this study
was comparable to previous international studies (Aktas, 2015, Chia et al., 2013; Grandi et al.,
2012; Ortiz, 2010). The mean rating of menstrual cramping at its worst was moderately higher
for adolescent females living in the US (O’Connell et al., 2006) than it was for the young adult
women in this current study. This may be further indication that some women may experience
improvements in menstrual cramping with age. Most importantly, the high prevalence of
moderate to severe menstrual cramping amongst participants suggests dysmenorrhea may be a
common problem for young women living in the United States.
In general, the results suggest that when women endorse menstrual cramping they tend
to disclose the negative impact it has on multiple areas of functioning, especially work around
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the home, physical activity, and social activity, all of which affect one’s well-being.
Additionally, a significant number of women endorsed their menstrual cramping had an impact
in school, and on their ability to concentrate. This is consistent with previous international
studies which suggested dysmenorrhea may be frequently responsible for reduced academic
performance (Chuamoor, Kaewmanee, & Tanmahasamut, 2012; Gagua, Tkeshelashvili, &
Gagua, 2012). As a result, dysmenorrhea is a significant burden for young women during a
crucial time in life, when both responsibility and productivity are expected to increase.
Furthermore, pain conditions that affect daily living so significantly typically warrant discussion
with healthcare providers, however, this study did not find this to be the case.
Despite high levels of pain and impact on functioning, nearly half of all participants had
not spoken to their healthcare providers at all about their dysmenorrhea symptoms within the last
year. International research suggests the prevalent belief that pelvic cramping is a normal part of
menstruation may be to blame for the lack of discussion with healthcare providers, as well as
embarrassment discussing menstruation (Berkley & McAllister, 2011; Chan et al., 2009; Ortiz,
2010). This is consistent with the current findings where 75% of participants disclosed moderate
to significant discomfort discussing menstrual cramping with their provider. These findings are
concerning due to previous research suggesting reluctance to discuss menstrual discomfort was
positively correlated with higher rates of dysmenorrhea (Aktas, 2015). Of the participants who
had previously spoken to a health care provider about their menstrual cramping, nearly half
reported it was not at all helpful.
The most common treatment strategies endorsed by participants was the use of shower or
baths, sleep, heat, and warm beverages. The same treatment strategies were also endorsed within
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international studies. These “home remedies” are likely passed down from mothers, and other
elder females. Despite research indicating NSAIDS are an effective treatment option for
dysmenorrhea, only 52% of women endorsed using them as treatment strategy (Daniels et al.,
2009; Osayande & Mehulic, 2014; Proctor & Faruqhar, 2006). Additionally, 20% of participants
used birth control medication to treat dysmenorrhea symptoms despite the unknown efficacy of
birth control medication in treating primary dysmenorrhea (Osayande & Mehulic, 2014; Ou et
al., 2012; Proctor & Faruqhar, 2006). Both the usage of birth control and the lack of using
NSAIDs may be due to the lack of in depth communication with treatment providers, leaving
women uninformed about effective treatment strategies.
When comparing participants in the low dysmenorrhea pain group to those in the high
dysmenorrhea pain group, there was a large difference in terms of the impact it had on
participants daily functioning. Those with higher pain levels were less able to keep up with their
activities of daily living. Those with higher pain were also more likely to have discussed their
dysmenorrhea with their healthcare provider at greater length and found their conversation with
their healthcare provider to be slightly more helpful than those with lower pain levels. However,
there was no significant difference between the high and low dysmenorrhea pain groups in terms
of their comfort level when discussing menstrual cramping with their healthcare provider. This
finding may suggest that those who have higher pain, causing a greater negative impact on their
lives, likely have more motivation to overcome the discomfort of discussing their menstrual
cramping with their healthcare provider.
Of the participants who endorsed dysmenorrhea, only 8.5% disclosed relevant diagnoses.
Most women in the study were experiencing primary dysmenorrhea, meaning their pelvic pain
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and cramping had not been labeled as a symptom of another reproductive organ disorder.
However, several participants indicated their provider suggested they may have either
endometriosis or polycystic ovaries, but they had not been formally diagnosed. For instance, one
participant wrote, “Obgyn won't diagnose because ‘There was no benefit of being diagnosed
with endometriosis. Even though I probably have it.’” This is concerning in light of a previous
study conducted on women surgically diagnosed with endometriosis, in which 84% had
previously disclosed menstrual pain to their healthcare provider (Greene, Stratton, Cleary,
Ballweg & Sinaii, 2009). In the process of seeking help two thirds of the participants in the
Greene et al. study were told by at least one physician that nothing was wrong with them. This
finding was even more likely to be true for women who first disclosed symptoms in adolescence,
when most women experience their first symptoms of endometriosis. Additionally, previous
studies have indicated the diagnostic process for endometriosis is longer for women experiencing
pain than it is for women experiencing infertility (Arruda, Petta, Abrao, & Benetti-Pinto, 2003;
Dmowski, Lesniewicz, Rana, Pepping, & Noursalehi, 1997). Greene et al. (2009) found it took
an average of roughly five years for women to receive a formal diagnosis of endometriosis, and
this was tripled for women who first discussed symptoms in adolescence. One possible barrier in
diagnosing endometriosis when menstrual cramping is the primary symptom is the shared
perception by both the physician and the patient that the patient is not ill due to the normalizing
of moderate to severe menstrual cramping (Ballard, Lowton, & Wright, 2006; Greene et al.,
2009).
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Social Considerations of Research Findings
Menstruation has been used as an excuse for women’s “unsuitability” in everything from
pursuing a college education to being elected into political positions and various other leadership
opportunities (Delaney et al., 1988). As Bobel states,
We walk a fine line between views of menstruation as incapacitating and
inconsequential.… Blaming biology for the behavior of women (or men) is a classically
anti-feminist position, but so is the failure to take women at their word and validate their
experiences (2010, p. 36-37).
However, while the effort is made to dismantle the idea that menstruation is debilitating for all
women, we must also acknowledge the problems it does present for a significant number of
women (Golub, 1985). Previous research suggests menstruation still remains largely negative in
both Western and non-Western cultures (Thurén, 1994). However, it is suggested by Berkley and
McAllister (2011), that times are changing, and today’s young women do not view menstruation
as such a taboo. The investigator of this study found this to be true, not only did participants
actively engage in further distributing the survey to their own communities, but several women
who were outside of the age range wrote the researcher to express a desire to share their own
experiences with menstruation.
Limitations
Notable limitations in the current study include the self-report measures, which may have
led to recall bias and possible over-reporting. Furthermore, it is possible women with more
negative experiences of menstruation were more likely to participate in the survey. Due to the
lack of validated measures regarding dysmenorrhea, the results of this study should be
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interpreted with caution. While participation was voluntary, and the survey took under 10
minutes to complete, several participants did not complete the questionnaire, also possibly
impacting the results. Given the age range and distribution methods used, most of the women in
this study were enrolled in university, living in the Pacific Northwest, and a majority identified
as white. Due to the lack of diversity amongst this population, this study may not be accurate
representation of the experiences of all women living within the United States. Particularly,
information gathered on impact on employment, treatment strategies, and communication with
health care providers may vary outside of the university system and may be impacted by cultural
traditions and disparities in access to health care (National Healthcare Quality and Disparities
Reports, 2011).
Future Research
Berkley and McAllistor (2011) previously challenged researchers in the pain community
to give moderate-to-severe dysmenorrhea its much-deserved place in pain research, and the
findings of this exploratory study provide further evidence for this necessary call to action.
Future research may benefit from developing validated measures of dysmenorrhea symptoms
and its impact on functioning. Additionally, communication with healthcare providers,
improving patient perception of provider treatment and investigating common beliefs regarding
menstrual cramping amongst both patients and providers all warrant further exploration. Possible
areas include: gathering data from healthcare providers regarding their experiences of
communicating with patients about menstrual concerns and treatment, assessing the efficacy of
treatment strategies for dysmenorrhea, exploring differences in rates of dysmenorrhea amongst
women who have experienced childbirth and of various age ranges, and assessing impact on
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employment on a larger sample of employed participants. Future research may also benefit from
collecting data from a more culturally diverse sample of the population. Additionally, data
gathered from medical providers on how they perceive and treat dysmenorrhea may be a
beneficial addition to the literature.
Conclusion
The present study found dysmenorrhea may have a high prevalence amongst young
women living within the United States. Of the 85% of participants who endorsed dysmenorrhea
symptoms, 70.1% rated their symptoms as moderate to severe, and 69.7% endorsed at least one
experience of severe pain within the last six months. Dysmenorrhea was positively correlated
with impaired functioning particularly in physical activity, social functioning, and activities
around the home. Participation in school and impairments to concentration were also frequently
endorsed. Despite high rates of pain, and impairment on functioning, nearly half of all
participants had not spoken to their health care provider at all within the last year about their
dysmenorrhea symptoms. Additionally, of those who had spoken to a health care provider about
their symptoms 46.3% found it to be not at all helpful. Participants endorsed using on average
4.75 treatment strategies, most of which were home remedies. One possible implication of these
findings is the potential delay in diagnosing endometriosis due to dysmenorrhea being
considered normal and therefore not assessed or treated. The implications of a delayed diagnosis
such as endometriosis are grave, potentially leading to delayed surgery, impacts on fertility, and
other consequences. Therefore, providers need to routinely ask about menstrual pain and
consider discussing treatment options with women who otherwise will continue to suffer in
silence.
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Appendix A
Informed Consent

Informed Consent: Exploring Women’s Experiences with Menstrual Cramping
I authorize Annika Johnson of the Graduate School of Clinical Psychology, George Fox
University, Newberg, Oregon, and/or any designated research assistants to gather information
from me on the topic of symptoms during menstruation.
I understand that the general purposes of the research are to evaluate the prevalence, impact, and
treatment of pain during menstruation. I understand that I will be asked to answer questions, and
that the approximate total time of my involvement will be under 10 Minutes. There is no
foreseeable risk to participating in this research. The information gathered in this survey may
benefit women’s health care providers by adding to the current literature on experiences during
menstruation.
I understand that my participation is voluntary and that I may refuse to participate or discontinue
my participation at any time without penalty or loss of benefits to which I am otherwise entitled.
I understand that if, after my participation, I experience any discomfort or have questions about
the research or my rights as a participant, I can contact Annika Johnson, MA
(ajohnson15@georgefox.edu) or Marie-Christine Goodworth, Ph.D, faculty supervisor
(mgoodworth@georgefox.edu), Graduate School of Clinical Psychology, 414 N Meridian St
V104, Newberg, OR 97132. I understand confidentiality of research results will be maintained
by the researcher, and my individual results will not be released without my written
consent. This survey was approved by the Institutional Review Board of the George Fox
University.
Upon completion of this survey you will be given the opportunity to provide your email if you
would like to be entered into a drawing to win one of several 10-dollar gift certificates to
Amazon. This information will be stored separately from your survey data, and will be kept safe
and secure.
By continuing on to the survey I am agreeing to authorize Annika Johnson of the Graduate
School of Clinical Psychology at George Fox University, and/or any designated research
assistants to gather information from me on the topic of symptoms during menstruation.
Thank you so much for your time and participation!
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Appendix B
Survey Questionnaire

Inclusion Criteria:
1. Are you female?
Yes
No
2. Are you between the ages of 18-28?
Yes
No
3. Are you currently living in the United States of America?
Yes
No
Questionnaire
4. What is your current age?
5. What is the highest-grade level you have completed?

6. What is your race/ethnicity? Please check all that apply
Non-Hispanic while or Euro-American
Black, Afro-Caribbean, or African American
Latino or Hispanic American
East Asian or Asian American
South Asian or Indian American
Middle Eastern or Arab American
Native American or Alaskan Native
Other
7. At what age did you experience your first period?
8. During the past 6 months, have your menstrual cycles been regular and predictable?
Never
Rarely
Sometimes
More often than not
Almost always
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9. During the past 6 months, how many menstrual periods have you experienced?
10. On average during the past 6 months, how much did you bleed during menstruation?
No bleeding
Very light bleeding or spotting
Light bleeding
Moderate bleeding
Heavy bleeding
11. During the past 6 months, what was the average length of your period?
12. Over the last 6 months have you experienced any of the following due to your menstrual
period, please check all that apply:
None
Mild
Abdominal cramping
Joint/muscle pain
Leg aches
Backache
Acne
Swollen or tender breasts
Feeling tired
Trouble sleeping
Upset stomach/Nausea
Bloating
Constipation/diarrhea
Headache/Migraine
Appetite changes
Trouble with concentration or memory
Tension, irritability, mood swings, or crying spells
Anxiety
Depression

Moderate

Severe

13. On average during the past 6 months, how would you rate your menstrual discomfort?
0 (no discomfort), 1, 2, 3, 4, 5 (moderate discomfort), 6,7, 8, 9, 10 (extreme discomfort)
For the purpose of this survey, pelvic pain/cramping involves pain in the lower
abdomen, back, and thighs, and may be accompanied by other symptoms such as
nausea, vomiting, diarrhea, and fatigue.
14. During the past 6 months, have you experienced any degree of pelvic pain or cramping
along with menstruation?
Yes
No
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15. On average during the past 6 months, how would you rate your menstrual pelvic pain or
cramps?
0 (no pain/cramping), 1, 2, 3, 4, 5 (moderate pain/cramping), 6,7, 8, 9, 10 (severe
pain/cramping)
16. During the past 6 moths, at its worst, how would you rate your menstrual pelvic pain or
cramps?
0 (no pain/cramping), 1, 2, 3, 4, 5 (moderate pain/cramping), 6,7, 8, 9, 10 (severe
pain/cramping)
17. During the past 6 months, on average, how many days of your period do you experience
pelvic pain/cramping?
1 day
2 days
3 days
Entire period
18. In the past 6 months, how much did pelvic pain or cramping during menstruation limit
you in your….
Paid work: Not at all, slightly, moderately, quite a bit, extremely, N/A
School work: Not at all, slightly, moderately, quite a bit, extremely, N/A
Work around the home: Not at all, slightly, moderately, quite a bit, extremely,
N/A
19. In the past 6 months, how many days of paid work or school work did you miss because
of pelvic pain or cramping?
20. In the past 6 months, have you lost wages due to your menstrual pain/cramping?
Yes
No
21. Approximately how much money did you lose due to your menstrual pelvic
pain/cramping
22. In the past 6 months, how much did pelvic pain or cramping during menstruation limit
you in your…
Physical activities: Not at all, slightly, moderately, quite a bit, extremely
Social or leisure activities: Not at all, slightly, moderately, quite a bit, extremely
Relationships with others: Not at all, slightly, moderately, quite a bit, extremely
Ability to concentrate: Not at all, slightly, moderately, quite a bit, extremely
Ability to sleep: Not at all, slightly, moderately, quite a bit, extremely
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23. During the past 6 months, which of the following have you used to treat your menstrual
related pelvic pain/cramps, please check all that apply:
Acetaminophen (Tylenol)
Pamprin or Midol
NSAID (Aspirin, Ibuprofen, Naproxin etc.)
Narcotics (Hydrocodone, Oxycodone)
Contraceptives (Birth control pills, patches, rings etc.)
Acupuncture
Massage
Herbal medicines
Warm beverage
Sleep
Postural adjustments
Yoga
Applying heat
Showers/baths
Exercise
Television or distraction
Special food and drink
Dietary/nutritional supplements
Alcohol
Marijuana
Other (please specify)
24. Have you ever had to seek emergency or same-day care due to menstrual related pelvic
pain/cramping?
Yes
No
25. I have discussed my menstrual pain with my healthcare provider within the last year
0 (not at all), 1, 2, 3, 4, 5 (Briefly discussed), 6,7, 8, 9, 10 (Discussed at length)
26. I feel comfortable discussing my menstrual pain with my healthcare provider
0 (not comfortable at all), 1, 2, 3, 4, 5 (Moderately comfortable), 6,7, 8, 9, 10 (Very
comfortable)
27. How helpful was talking to your healthcare provider about your menstrual pain?
0 (not helpful at all), 1, 2, 3, 4, 5 (neutral), 6,7, 8, 9, 10 (Very helpful)
28. During the past 6 months, have you used any of the following contraceptive methods?
The pill
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IUD
Patch/injection
Implant
Ring
None
Other (Please specify)
29. Have you ever been diagnosed with a reproductive organ disorder, please check all that
apply:
Endometriosis
Adenomyosis
Uterine fibroids
Polycystic Ovary Syndrome
Infection
N/A
Other (Please Specify)
30. Are you currently pregnant?
Yes
No
31. Have you ever been pregnant?
Yes
No
32. Have you ever given birth?
Yes
No
33. How did you hear about this survey?
University setting
E-mail
Friend or peer
Other
34. Would you like to be entered into a drawing to win one of at least 20 $10.00 Amazon gift
cards?
Yes
No
Thank you for your participation. In order to keep your survey answers anonymous, please follow the
link below to enter your E-mail address in the Amazon gift card drawing. Email addresses provided
will in no way be linked to survey responses.
https://www.surveymonkey.com/r/JXWZZ6Q
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Appendix C
Curriculum Vitae

Education
Doctoral Candidate of Clinical Psychology
Graduate School of Clinical Psychology (APA-Accredited)
George Fox University Newberg, OR

Anticipated April 2020

Dissertation: The Prevalence and Impact of Dysmenorrhea in Young Women within the United
States
Master of Arts in Clinical Psychology
Graduate School of Clinical Psychology (APA-Accredited)
George Fox University, Newberg, OR

April 2017

Bachelor of Science in Psychology
Minor in Health
Magna Cum Laude
Western Oregon University, Monmouth, OR

June 2014

Supervised Clinical Experience
Lancaster Family Health Center
June 2018- Present
Salem, OR
Title: Pre-Intern Behavioral Health Trainee
Organization: Yakima Valley Farm Workers Clinic
Treatment Setting: Federally Qualified Health Clinic
Treatment method: Brief therapeutic intervention with individuals, families, couples, and in
groups
Populations: Culturally diverse, low income populations across the lifespan, and LGBTQ+ care
Supervisor: Dr. Lola White, PsyD
Duties:
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Provide brief intervention using empirically supported practice, including Acceptance &
Commitment Therapy, CBT, and Motivational Interviewing
Co-facilitate group therapy with transgender and gender non-conforming patients to
provide additional support throughout transitioning process
Developed a group medical visit curriculum for patients with diabetes
Continued daily patient care through brief therapeutic modalities and assessment

Lancaster Family Health Center
July 2017- June 2018
Salem, OR
(Please see information above)
Title: Practicum II Behavioral Health Trainee
Supervisor: Dr. Lola White, PsyD
Duties:
 Provide brief intervention using empirically supported practice, including Acceptance &
Commitment Therapy, CBT, and Motivational Interviewing
 Administer thorough screening and appropriate referrals in cases of ADHD, autism, and
dementia
 Coordinate care in a multidisciplinary setting with medical providers, nursing staff,
registered dietician, and social workers
 Engaged in patient care at other Yakima Valley Farm Workers clinics in the Willamette
Valley for additional clinic experience
 Participate in Primary Care Health Home meetings to improve patient access to
preventative screenings and healthcare services, as well as to monitor clinic progress for
grant funding
George Fox Behavioral Health Center
Aug 2016- June 2017
Newberg, OR
Title: Practicum I Student Therapist
Treatment Setting: Outpatient Community Health Clinic, Catalyst alternative high school
Treatment Method: Individual therapy, couples therapy, group therapy
Populations: Culturally and economically diverse populations across the lifespan
Supervisors: Joel Gregor, PsyD and Kristie Knows His Gun, PsyD
Duties:
 Offered both long-term and brief interventions using Interpersonal, and Acceptance &
Commitment Therapy methods
 Administer psychological assessment to adult clients to determine diagnostic clarification
and fitness for employment
 Developed and piloted group therapy curriculum for adolescents with anxiety attending a
local alternative high school
 Responsible for maintaining my own patient schedule and billing
George Fox University Pre-practicum
Newberg, OR

Sep 2015- Apr 2016
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Title: Pre-practicum Student Therapist
Treatment Setting: University
Populations: George Fox University undergraduate students
Supervisors: Glena Andrews, PhD and Shaun Davis, TA, M.A.
Duties:
 Provided individual intervention from a person-centered therapeutic framework with-in a
10-session limit
 Formulated diagnostic impressions, treatment plans, and maintained client notes

Selected Relevant Experience
George Fox University Idea Center
Sep 2015- Nov 2016
Newberg, OR
Title: Assistant Career Coach
Setting: University career center
Population: Undergraduate and graduate students enrolled at George Fox University
Supervisor: Elise Gibson, M.S.
 Provided career counseling to university students exploring future employment
opportunities during one-on-one sessions
 Collaborated with students to help them identify their strengths and articulate their
experiences throughout the job application process
Marion County District Attorney’s Victim Assistance Office
Jan 2012- Jul 2015
Salem, OR
Title: Victim’s Advocate
Treatment Setting: Marion County emergency rooms and law enforcement agencies
Populations: Adolescent, adult, and elderly females from diverse cultural and socioeconomic
backgrounds
Supervisors: Molly Hawkins and Kathie Beach
Duties:
 Responded in-person to hospitals and law enforcement agencies during 24-hour shifts to
provide crisis intervention, information, resources and support to survivors of sexual
assault
 Collaborated with law enforcement and medical professionals to coordinate treatment,
advocating on behalf of the survivor’s needs
Abby’s House Center for Women and Families
Aug 2012- Jun 2013
Western Oregon University, Monmouth, OR
Title: Advocate
Treatment Setting: University
Populations: Undergraduate students and faculty and staff, primarily undergraduate females
Supervisor: Mary Ellen Dello-Stritto, PhD
Duties:
 Facilitated process group discussions on domestic violence, sexual assault, and
disordered eating
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Planned and implemented campus-wide awareness raising programs by collaborating
with the Health and Counseling Center and the bystander intervention program Green
Dot

Published Manuscripts
Johnson, A. M., & Hoover, S. M. (2015). The Potential of Sexual Consent Interventions on
College Campuses: A Literature Review on the Barriers to Establishing Affirmative Sexual
Consent, Pure Insights, 4(5). Retrieved from http://digitalcommons.wou.edu/pure/vol4/iss1/5

Presentations
Marston, A., Johnson, A., Wenger, A., David, A., & Goodworth, M.C. (2018). Body shame
differences between clergy and non-clergy in women in the church of the Nazarene. Poster
presented at American Psychological Association, San Francisco, California.
Ramirez, S., Leonce, C., Johnson, A., Campo, V., & Gathercoal, K. (2018). Efficacy of a
multidisciplinary response to treating chronic pain and depressive symptoms in a rural
population. Poster presented at the Oregon Psychological Association, Portland, Oregon.
Johnson, A., & Summers, W. (2017). Is this normal? Discussing sexual dysfunction in therapy.
Presented at George Fox University, Newberg, Oregon.
Davis, S., Terman, J., Speck, C., Malone, M., Goins, N., Johnson, A., & Turgeson, J. (2016)
Assessment of Pediatric Behavioral Health Services in a Primary Care Setting. Poster presented
at the Oregon Psychological Association, Portland, Oregon.
Johnson, A., Johnston, M., Bostwick, J., Rodriguez, C., & Rubio, X. (2015). Treatment Integrity
for Culturally Accommodated Treatment for Latino Adolescents. Presented at the Oregon
Academy of Sciences, Portland, Oregon.
Bostwick, J., Johnson, A., & Ahrensbach, M. (2014). Social justice identity of mental
health counselors. Poster presented at the Academic Excellence Showcase, Western Oregon
University, Monmouth, Oregon.
Hoover, S. M., & Johnson, A. (2014). Pediatric death, organ donation decision making,
and parental grief. Presented at the Annual Convention of the Western Psychological
Association, Portland, Oregon.

Research Experience
Dissertation Topic: The Impact of Dysmenorrhea in the Lives of Young Women within the
United States
Committee: Marie-Christine Goodworth, PhD (Chair), Kathleen Gathercoal, PhD, William
Buhrow, PsyD
 Largest sample of dysmenorrhea amongst young women in the US, n = 976
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Assessed level of pain, impact on functioning, treatment strategies, and communication
with healthcare providers

Consultation Project: What is the current level of cultural awareness amongst Graduate
School of Clinical Psychology students?
 Research conducted on graduate students’ level of multicultural awareness and
multicultural exposure
 Used quantitative and focus group data to provide suggestions on improving diversity
training
Research Team Member
Jan 2016- Present
Marie-Christine Goodworth, PhD., George Fox University, Newberg, OR
 Provide edits on working manuscripts
 Collaborate with team members on dissertation topics and engage in supplemental
research
o Mental health outcomes in the treatment of Tinnitus
o Body shame amongst clergy and non-clergy women
o Multidisciplinary treatment of chronic pain and depression in a rural setting
 Participate in qualitative research methods and provide feedback to peers
o Shame and sexuality amongst women within the Catholic church
o Staff perspectives of treating pain within a Federally Qualified Health Center
Research Assistant
Feb 2014- Jun 2015
Stephanie Hoover, PhD., Western Oregon University, Monmouth, OR
 Assisted with the analyses of multiple studies
o Pediatric death, organ donation, and parental grief
o Treatment adherence for culturally adapted substance abuse treatment for Latino
adolescents
o Intersectional and social justice identities amongst mental health professionals
o Qualitative research methods for sexual trauma survivors
 Analyzed qualitative data using Grounded Theory method
 Revised introduction, results, and discussion of manuscripts
 Presented material at multiple psychological conferences
Primary Investigator
Jan 2014- June 2014
Title: Relationship History and its Effect on the Perception of Sexual Consent
Psychology 467/468, Western Oregon University, Monmouth, OR
 Designed and conducted IRB approved original study with university participants
 Performed statistical analysis with SPSS and reported findings in both an APA formatted
manuscript and in a power point presentation

Leadership Experience
American Psychological AssociationSociety for Health Psychology Campus Representative

Sept 2017-Aug 2018

DYSMENORRHEA



54

Promoted health psychology opportunities and generate interest in topics of health
psychology
Hosted informational panels and guest speakers to discuss relevant topics on health
psychology

GFU Graduate School of Clinical PsychologyAug 2017- Aug 2018
Gender and Sexuality Student Interest Group Leader
 Facilitated student dialogues on topics of gender, sexuality, and identity issues
 Presented didactics on topics of gender, sexuality, and identity issues
American Psychological AssociationSept 2016- Aug 2018
Psychology of Women Campus Representative
 Hosted campus events to facilitate learning and increase student dialogue regarding
feminist issues
 Submitted blog posts on relevant feminist topics published on the Division 35 FEMPOP
website

Teaching Experience
Teaching Assistant
Aug 2018- Dec 2018
Cognitive Behavioral Therapy
Dr. Mark McMinn, George Fox University- Graduate School of Clinical Psychology
Newberg, OR
 Met with small student groups weekly to provide encouragement and feedback regarding
theoretical conceptualization and intervention application
 Co-facilitated lecture on the role of CBT & ACT interventions within the primary care
setting
Teaching Assistant
Aug 2013- Dec 2013
Developmental Psychology (PSY 311)
Dr. Tamina Toray, Western Oregon University, Monmouth, OR
 Provided individual feedback to students regarding performance on exams and papers
 Facilitated group study sessions and maintained routine office hours to meet with
students
 Assisted in the creation of and the grading for quizzes, exams, and observational research
papers

Supervision Experience
Peer Supervisor
Oct 2018-Present
Yakima Valley Farm Worker’s Clinic, Willamette Valley, OR
 Meet bi-weekly via webcam to provide additional support & supervision to another
practicum student new to the integrated care model
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4th Year Mentor
Aug 2018- Present
Clinical Team, GFU Graduate School of Clinical Psychology, Newberg OR
 Meet weekly with practicum 1 student to provide additional supervision
 Oversee clinical work, provide mentorship, and guide professional development
 Receive supervision of supervision from Dr. Kristie Knows His Gun, PsyD

Professional Trainings and Certificate Courses
Gender and Sexuality
George Fox University: Graduate Certificate Course, Newberg OR
Brooke Kuhnhausen, PhD

Sept 2018-Nov 2018

Transgender Health: Best Practices in Advanced Medical Treatment
The World Professional Association for Transgender Health, Portland, OR
Lin Fraser, EdD, Randi Ettner, PhD, Jess Guerriero, MSW, MA, Dan Karasic, MD
Attachment in Psychotherapy
George Fox University: Graduate Certificate Course, Newberg OR
Brooke Kuhnhausen, Phd

Sept 2018

Jan 2018- April 2018

Acceptance & Commitment Therapy: An Experiential and Practical Introduction
Portland Psychotherapy Clinic, Portland, OR
Jason Luoma, PhD & Jenna LeJeune, PhD

Dec 2017

Clinical Colloquia and Grand Rounds
The History and Application of Interpersonal Psychotherapy
George Fox University, Newberg, OR
Carlos Taloyo, PhD

Feb 2018

Telehealth
George Fox University, Newberg, OR
Jeff Sordahl, PsyD

Nov 2017

Using Community Based Participatory Research (CBPR) to Promote
Oct 2017
Mental Health in American Indian/Alaska Native (AI/AN) Children, Youth and Families
George Fox University, Newberg, OR
Eleanor Gil-Kashiwabara, PsyD
Domestic Violence: A Coordinated Community Response
George Fox University, Newberg, OR
Patty Warford, PsyD & Sgt Todd Baltzell

Mar 2017

Native Self Actualization: Its assessment and application in therapy
George Fox University, Newberg, OR
Sydney Brown, PsyD

Feb 2017
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When Divorce Hits the Family: Helping Parents and Children Navigate
George Fox University, Newberg, OR
Wendy Bourg, PhD

Nov 2016

Sacredness, Naming, and Healing: Lanterns Along the Way
George Fox University, Newberg, OR
Brook Kuhnhausen, PhD

Oct 2016

Managing with Diverse Clients
George Fox University, Newberg, OR
Sandra Jenkins, PhD

Mar 2016

Neuropsychology: What Do We Know 15 Years After the Decade of the Brain?
And Okay, Enough Small Talk. Let’s Get Down to Business!
George Fox University, Newberg, OR
Trevor Hall, PsyD and Darren Janzen, PsyD

Feb 2016

Let’s Talk About Sex: Sex and Sexuality Applications for Clinical Work
George Fox University, Newberg, OR
Joy Mauldin, PsyD

Oct 2015

Relational Psychoanalysis and Christian Faith: A Heuristic Dialogue
George Fox University, Newberg, OR
Marie Hoffman, PhD

Oct 2015

Other Certificates and Trainings
Protecting Human Research Participants
National Institutes of Health Online Training

Sept 2018

Basic Life Support for Healthcare Provider
George Fox University, Newberg, OR

Nov 2017

Screening, Brief Intervention, Referral to Treatment (SBIRT)
George Fox University, Newberg, OR

Mar 2016

Collaborative Assessment and Management of Suicidality (CAMS)
George Fox University, Newberg, OR

Mar 2016

Organizational Memberships
The World Professional Association for Transgender Health
Society of Menstrual Cycle Research
American psychological Association, Society of Health Psychology

Since 2018
Since 2017
Since 2017
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American Psychological Association, Student Affiliate
American Psychological Association, Psychology of Women
GSCP Clinical Health Psychology Student Interest Group
GSCP Diversity Student Interest Group
GSCP Gender and Sexuality Student Interest Group
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Since 2015
Since 2015
Since 2015
Since 2015
Since 2015

Awards
Outstanding Graduating Student in Psychology
Western Oregon University, Monmouth, OR

Spring 2014

